---
schema_version: "secwatch.filing_event.v1"
accession: "0000950170-24-138782"
form_type: "8-K"
ticker: "ELDN"
cik: "0001404281"
company_name: "Eledon Pharmaceuticals, Inc."
filed_at: "2024-12-20T23:59:59+00:00"
generated_at: "2026-05-29T00:12:49.176043+00:00"
event_type: "other_material"
sentiment: "neutral"
materiality_score: 0.3
calibrated_materiality_score: 0.3
confidence: "high"
source: SEC EDGAR
---

# Eledon amends CEO Performance Bonus; increases max payout to $15M at $1.5B market cap

## Summary
- CEO David-Alexandre Gros' employment agreement amended to modify Performance Bonus market value cap.
- Bonus threshold of $6M at $600M market cap remains unchanged.
- Maximum bonus increased to $15M at $1.5B market cap using linear interpolation.
- Agreement entered Dec 16, 2024; filed Dec 20, 2024.

## SEC filing metadata
- accession: 0000950170-24-138782
- form_type: 8-K
- ticker: ELDN
- cik: 0001404281
- company_name: Eledon Pharmaceuticals, Inc.
- filed_at: 2024-12-20T23:59:59+00:00
- event_type: other_material
- sentiment: neutral
- materiality_score: 0.3
- calibrated_materiality_score: 0.3
- confidence: high
- sec_items: 5.02, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1404281/000095017024138782/0000950170-24-138782-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1404281/000095017024138782/eldn-20241216.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0000950170-24-138782
- JSON: https://secwatch.observer/filing/0000950170-24-138782.json
- Plain text: https://secwatch.observer/filing/0000950170-24-138782.txt

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.